510(k) Report

De Novo · Granted

Granted

vPatch

DEN210012De NovoGranted Nov 23, 2021238-day reviewClass II21 CFR 876.5026

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Virility Medical · QRC Non-Implanted Electrical Stimulation Device For Management Of Premature Ejaculation

Granted on Nov 23, 2021 as a new device type through De Novo after a 238-day review. 3 later devices descend from it.

Decided
Nov 23, 2021
Review
238 days
Class
Class II
Product code
QRC
Recalls
None

3 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2023: 1 descendant cleared2026: 1 descendant cleared2025: 1 descendant cleared2020202220242026
  1. This deviceDEN210012 vPatchVirility Medical · 2021
  2. Descendant · cites it directly · 2 of its ownK223595 vPATCHVirility Medical, Ltd. · 2023
  3. Descendant · 2 generations on · 0 of its ownK252809 in2 Smart (in2S)Virility Medical, Ltd. · 2026
  4. Descendant · 2 generations on · 0 of its ownK241897 MORMorari, Inc. · 2025

Most influential descendants

Showing 3 of 3 · See all
  • K223595vPATCHVirility Medical, Ltd. · 2023 · cites it directly2descendants
  • K252809in2 Smart (in2S)Virility Medical, Ltd. · 2026 · 2 generations on0descendants
  • K241897MORMorari, Inc. · 2025 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)DEN210012vPatchVirility Medical2021—
+1K223595vPATCHVirility Medical, Ltd.2023—
+2K252809in2 Smart (in2S)Virility Medical, Ltd.2026—
+2K241897MORMorari, Inc.2025—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202310
202510
202610
FIG. 1 — Lineage of DEN210012, 2021–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA De Novo database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QRC? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new QRC device

  1. #1 K252809 in2 Smart (in2S)score 11.4 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

Does it have a predicate?

De Novo decisions do not claim a predicate device.

What descends from it? (3)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K223595vPATCHVirility Medical, Ltd.20232

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K223595 (Virility Medical, Ltd., 2023) has gone furthest, with 2 descendants of its own.

How does its category compare?

All QRC devices

QRC Non-Implanted Electrical Stimulation Device For Management Of Premature Ejaculation: FDA decisions, review times, recalls and adverse event reports over 20 years. 2021, this device’s year, is highlighted.

FDA decisions per year · QRC

1in 2025

2021: 12023: 12025: 12026 (partial year): 1
2007high 1 (2021) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QRC

Too few QRC 510(k)s in any year since 2007 to give a median.

Recalls per year · QRC

No recall names QRC since 2007.

Adverse event reports per year · QRC

No MAUDE report names QRC since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20211—00
20220—00
20231—00
20240—00
20251—00
20261—0—

What is it indicated for?

The vPatch is indicated for management of premature ejaculation in males who ejaculate after intromission. It is designed to increase the time between arousal and ejaculation by delivery of short duration, low-intensity electrical stimulation to the perineal muscles and nerves during intercourse.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “DEN210012: vPatch.” Lineage record from FDA De Novo data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/DEN210012

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026